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Developing efficacious vaccines against enteric diseases is a global challenge that requires a
better understanding of cellular recruitment dynamics at the mucosal surfaces. The current
paradigm of T cell homing to the gastrointestinal (GI) tract involves the induction of 47
and CCR9 by Peyer’s patch and mesenteric lymph node (MLN) dendritic cells (DCs) in a
retinoic acid–dependent manner. This paradigm, however, cannot be reconciled with reports
of GI T cell responses after intranasal (i.n.) delivery of antigens that do not directly target
the GI lymphoid tissue. To explore alternative pathways of cellular migration, we have
investigated the ability of DCs from mucosal and nonmucosal tissues to recruit lymphocytes
to the GI tract. Unexpectedly, we found that lung DCs, like CD103+ MLN DCs, up-regulate
the gut-homing integrin 47 in vitro and in vivo, and induce T cell migration to the GI
tract in vivo. Consistent with a role for this pathway in generating mucosal immune
responses, lung DC targeting by i.n. immunization induced protective immunity against
enteric challenge with a highly pathogenic strain of Salmonella. The present report demonstrates novel functional evidence of mucosal cross talk mediated by DCs, which has the
potential to inform the design of novel vaccines against mucosal pathogens.
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Because efficient trafficking of immune cells
to the gastrointestinal (GI) tract is critical for
host defense against pathogenic challenge, study
ing cellular recruitment pathways to the GI
tract is the key to developing novel vaccines
against mucosally transmitted diseases, including
HIV-1 infection.
Naive T cells acquire the capacity to migrate
to extra-lymphoid tissues once activated by
their cognate antigen (Butcher et al., 1999; von
Andrian and Mackay, 2000). These antigenexperienced effector T cells migrate preferen
tially to the tissues where they first encountered
the antigen (Kantele et al., 1999; Campbell and
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Butcher, 2002). For example, early observations
demonstrated that cells activated in the GI tract
home back to the intestinal effector sites (Cahill
et al., 1977; Hall et al., 1977). Integrin 47
and chemokine receptor 9 (CCR9) are among
the best studied gut-specific homing molecules
(Berlin et al., 1995; Zabel et al., 1999). The
47 ligand mucosal addressin cell adhesion
molecule-1 (MAdCAM-1) mediates recruit
ment of T cells to the intestinal lamina propria
(Berlin et al., 1995), and the CCR9 ligand TECK,
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lamina propria (SILP; Esplugues et al., 2011). Furthermore,
Ciabattini et al. (2011) have demonstrated that after i.n.
immunization, antigen-specific T cells are generated in the
mediastinal LN and migrate to the MLN in an 47- and
CD62L-dependent manner. Additionally, it is known that lungs
harbor prominent extrahepatic stores of vitamin A (Okabe
et al., 1984; Dirami et al., 2004). Its metabolite, RA, plays an
important role in pulmonary alveolar development (Dirami
et al., 2004) and has a putative therapeutic role in emphy
sema (Massaro and Massaro, 1997). Finally, although RA pro
duction has been considered to be the forte of gut-resident
DCs, other DC populations also express RALDH, particu
larly lung-resident DCs that express RALDH-2 (Heng and
Painter, 2008; Guilliams et al., 2010). However, the ability of
lung DCs to induce GI-specific T cell homing has not yet
been reported.
All of the aforementioned factors led us to hypothesize that
lung DCs would up-regulate the expression of gut-homing
molecules integrin 47 and CCR9 on T cells, which in
turn would license the migration of T cells to the GI tract.
Our hypothesis was made credible by the concept of a com
mon mucosal immunological system proposed by Bienenstock
et al. (1978) more than 30 years ago. Indeed, there is increasing
appreciation of the mucosal immune system as an integrated
network of tissues, cells, and effector molecules, although the
cellular factors that link different mucosal compartments are
not well understood (Gill et al., 2010).
In this study, we show that lung DCs can imprint expres
sion of the gut-homing integrin 47 and CCR9 on cocultured T cells in vitro and on adoptively transferred cells
in vivo, licensing T cells to migrate to the GI lamina propria
and confer protective immunity against intestinal pathogens.
We define a new pathway of DC-mediated mucosal cross talk
and challenge the existing dogma that only GI-resident DCs
can recruit antigen-specific T cells back to the gut.
RESULTS
Lung DCs induce expression of integrin 47
and CCR9 on T cells in vitro and in vivo
We conducted a screen to examine the ability of mucosal
and nonmucosal DCs to induce gut-homing integrin-47
and CCR9 expression. CD11c+ cells were isolated from
murine lung, spleen (SpDC), MLNs, and skin-draining LNs
(SkDC) and co-cultured with CFSE-labeled T cells from
OVA-reactive CD4+ T cells from OT-II mice at a ratio of
1:2 DC/T cells for 5–7 d. Unexpectedly, we observed that
the expression of integrin 47 and CCR9 was significantly
up-regulated by lung DCs, similar to MLN DCs, with 47
and CCR9 up-regulation most prominent on proliferating
(CFSElo) cells (Fig. 1, a–c).
To test whether lung DCs can up-regulate 47 in vivo,
we adoptively transferred CFSE-labeled CD45.1+ OT-II cells
to naive CD45.2 mice and immunized the mice after 2 h
with OVA protein and polyICLC delivered i.n., s.c., i.t., or
orally (per os; p.o.). On day 4 after immunization, the per
centage of CD45.1+V2+CD4+CFSElo cells expressing 47
Lung dendritic cells' intestinal homing | Ruane et al.
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expressed by small intestinal epithelial cells, recruits T cells to the
small bowel (Zabel et al., 1999).
DCs are well recognized as the initiators of the adaptive
immune response (Steinman and Cohn, 1973), as well as me
diators of tolerance to self-antigens in steady-state conditions
(Hawiger et al., 2001). Additionally, there is increasing evi
dence regarding the role played by DCs as conductors of
immunological traffic to the skin and the GI tract ( JohanssonLindbom et al., 2003, 2005; Mora et al., 2003, 2005;
Sigmundsdottir et al., 2007). DCs can imprint T cells to mi
grate to the tissue in which the T cells were originally activated.
For example, gut-associated DCs induce the gut-homing re
ceptors 47 and CCR9 on T cells upon activation ( JohanssonLindbom et al., 2003; Mora et al., 2003; Stagg et al., 2002).
RA is necessary and sufficient to induce gut-homing
receptors on T cells (Iwata et al., 2004). The main pathway of
RA biosynthesis in vivo is dependent on the intracellular oxi
dative metabolism of retinol (Napoli, 1999; Duester, 2000),
catalyzed by a family of alcohol dehydrogenases including
retinal dehydrogenase (RALDH), a class I aldehyde dehydrog
enase that mediates the irreversible oxidation of retinal to
RA. RA in turn is thought to induce RALDH-2 in a positive
feedback loop (Yokota et al., 2009; Hammerschmidt et al.,
2011; Villablanca et al., 2011) and RA levels correlate with
the ability of the intestinal DCs to induce gut-tropic T cells.
Vitamin A is introduced via dietary or biliary sources ( JaenssonGyllenbäck et al., 2011). Among the cellular sources of RA
in the intestinal mucosa are DCs (Iwata et al., 2004), stromal
cells (Hammerschmidt et al., 2008; Molenaar et al., 2009),
intestinal epithelial cells (Bhat, 1998; Lampen et al., 2000),
and intestinal macrophages (Denning et al., 2007), with the
DCs likely playing a key role in the induction of gut-homing
phenotype on T cells. Among the intestinal DCs, the CD103+
DC subsets express high levels of RALDH-2 and are capable of
generating high levels of RA (Johansson-Lindbom et al., 2005;
Coombes et al., 2007; Sun et al., 2007; Jaensson et al., 2008).
In contrast, the CD103CD11b+CX3CR1+ macrophagelike population in the intestinal lamina propria expresses
RALDH-1 and not RALDH-2 and exhibits a lower RAproducing capacity (Schulz et al., 2009; Denning et al., 2011),
and therefore a decreased capacity to induce gut-homing
potential on T cells ( Jaensson et al., 2008).
Collectively, a paradigm has emerged wherein only the
intestinal CD103+ DCs, which are capable of metabolizing
vitamin A, can induce GI-specific homing on T cells (Jaensson
et al., 2008). This paradigm however, is difficult to reconcile
with reports of GI T cell responses after i.n. delivery of anti
gens that do not directly target the GI lymphoid tissue. For
example, mice infected i.n. with influenza virus show no
activated virus-specific CD8+ T cells in the mesenteric LNs
(MLNs) or Peyer’s patches (PPs), yet flu-specific CD8+ cells
within the lung-associated tissues express 47 and memory
CD8+ T cells are established within the small intestinal epi
thelium (Masopust et al., 2010). Similarly, a recent study dem
onstrates that i.n. challenge with H1N1 influenza results in
the accumulation of TH17 cells within the small intestinal
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was determined in the blood, lung, and spleen. As shown
in Figs. 1 (d and e), a significantly higher percentage of
CFSElo47+ cells were induced in the blood, lung, and spleen
after i.n., i.t., and p.o. immunization than in the blood or
spleen after s.c. immunization. Similar findings were observed
in the case of CD8+OT-I cells (unpublished data).
We next examined the ability of lung DC subsets to in
duce 47. Lung MHC-II+CD11chi DCs (gating strategy
shown in Fig. S1) were FACS-sorted into CD103+CD11b
JEM Vol. 210, No. 9

and CD11b+CD103 DC populations and co-cultured with
CFSE-labeled OT-II cells. Unexpectedly, both CD103+
CD11b and CD11b+CD103 lung DC subsets induced 47
integrin, with expression of 47 being even higher in the
CD11b+CD103 populations. As previously described (Jaensson
et al., 2008), among the MLN DCs, CD103+CD11b DCs
induced high levels of 47, whereas CD11b+CD103 DCs
did not (Fig. 2, a and b). Additionally, the lung CD11b+CD103
population was sorted into CD24+CD64 and CD24CD64+
1873
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Figure 1. Lung DCs induce integrin
47 and CCR9. (A–C) CD11c+ DCs isolated
from the lung, spleen, skin-draining LNs, or
MLNs were pulsed with OVA and cultured
with CFSE-labeled OT-II T cells at a ratio of 1:2
for 5–7 d. (A) T cell expression of 47 (top)
and CCR9 (bottom) was measured by flow
cytometry and plotted against CFSE dilution.
(B and C) Quantification of the number of
proliferated (CFSElo) 47+ (B) or CCR9+ (C)
cells showing cumulative data from three
independent experiments. (D and E) CFSElabeled CD45.1+V2+CD4+OT-II cells were
transferred into naive CD45.2+ recipients. 2 h
after transfer, mice were immunized with OVA
protein + polyICLC or cholera toxin via the
indicated route, and the percentage of
CFSEloCD45.1+V2+CD4+ cells expressing
47 was determined in blood, lung, and
spleen 4 d after immunization. (D) Representative flow cytometry data showing CFSE
dilution versus 47 expression. (E) Cumulative data from three independent experiments
showing frequency of 47+CFSElo cells
among total V2+CD4+ cells.

Lung DCs license T cells to migrate
to the intestinal lamina propria via 47 induction
Targeting of lung DCs by i.n. delivery (Vermaelen et al.,
2001) was confirmed in a time course experiment (unpub
lished data) where fluorescently labeled antibodies directed
against CD11c were administered to C57BL/6 mice i.n. Both
CD103+CD11b and CD11b+CD103 DC subsets were

targeted in the mediastinal LNs and lungs, with the peak
labeling occurring 24 h after antibody administration. How
ever, we could not detect antibody-labeled cells in the spleen,
MLN, or the GI tissues even after 72 h. To rule out a possible
role of gastric acid or GI proteases, cleaving the injected anti
bodies, orally delivered CD11c was administered to C57BL/6
mice. Peak labeling was detected in the small intestines after
16 h, targeting the CD11b+ population (unpublished data).
Therefore, transport of labeled antibodies through the GI
tract does not affect its ability to be used to stain gut DCs in
vivo. To confirm this, we compared i.n. and intratracheal (i.t.)
delivery of fluorescent antibodies and found that i.t. immuni
zation targets DCs in the lung similar to those targeted by i.n.
immunization (unpublished data).
We next conducted a time course experiment to study the
kinetics of induction of integrin 47 and the migration of
adoptively transferred cells into the GI tissues: SILP, colon, and
MLNs. CFSE-labeled CD45.1+ OT-II cells were adoptively
transferred to naive CD45.2 recipients that were immunized
after 2 h with OVA protein and polyICLC-delivered i.n. We

Figure 2. Lung CD103+ and CD24+11b+ DCs
induce integrin 47 and CCR9 in vitro. (A and
B) MHCII+CD11chiCD11b+CD103 and MHCII+CD11chi
CD11bCD103+ DCs were flow-sorted from the lung
or MLN, pulsed with OVA, and cultured with CFSElabeled OT-II T cells at a ratio of 1:2 for 5–7 d.
(A) T cell expression of 47 induced by lung DCs (top)
and MLN DCs (bottom) was measured by flow cytometry and plotted against CFSE dilution. (B) Quantification of the number of proliferated (CFSElo) 47+
cells showing cumulative data from three independent experiments. (C–E) Lung-derived MHCII+CD11chi
CD103CD11b+CD24+ and MHCII+CD11chiCD103
CD11b+CD64+ cells were flow-sorted. Additionally,
MHCII+CD11chi DCs were isolated from skin-draining
LNs. These DCs were pulsed with OVA and cultured
with CFSE-labeled OT-II T cells at a ratio of 1:2 for
5–7 d (C) T cell expression of 47 (top) and CCR9
(bottom) was measured by flow cytometry and plotted
against CFSE dilution. (D and E) Quantification of the
number of proliferated (CFSElo), 47+ (D) or CCR9+
(E) cells showing cumulative data from three independent experiments.
1874
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populations. We used these markers to distinguish between
macrophages and DCs contained within the heterogeneous
CD11b+ population (Langlet et al., 2012; Tamoutounour
et al., 2012). Additionally, although not the focus of this study,
a combination of MAR-1 and CD64 can also be used to dis
tinguish between cDCs and MoDCs contained within the
CD11b population (Plantinga et al., 2013).We observed strik
ing differences between the CD24+ and CD64+ subpopula
tions, with the CD11b+CD24+ cells inducing both integrin
47 and CCR9. In contrast, the CD11b+CD64+ popula
tion was poor in inducing both T cell proliferation and guthoming molecule induction (Fig. 2, c–e).

Ar ticle

tested for the induction of integrin 47 on the transferred
cells on days 1, 2, 3, 4, and 7 after transfer and quantified the
frequency of transferred cells in GI tissues at the same time
points (Fig. 3, a and b). Proliferation of the transferred cells was
first detected in the mediastinal LNs on day 2 after transfer. On
day 3, a sharp rise in the expression of integrin 47 was noted
on the transferred cells in the mediastinal LNs and the lungs,
peaking at day 4 and regressing by day 7.The frequency of trans
ferred CD45.1+V2+CD4+ T cells showed a striking rise on
day 4 in the GI tissues (SILP, colon, and MLNs) corresponding

to the peak expression of integrin 47 on lung and mediasti
nal LN–resident transferred cells. Additionally, we did not de
tect proliferation of the CFSE-labeled CD45.1+ OT-II cells in
the MLN on days 1, 2, and 3.The earliest site, where T cell pro
liferation was observed after i.n. immunization, was the medi
astinal LNs (Fig. 3 c). In contrast, proliferating cells were
detected in the MLNs by day 4, suggesting that T cell activation
initially occurred in the mediastinal LNs and not the MLNs.
Next, we wanted to confirm that the transferred
CD45.1+V2+CD4+ T cells detected in the GI tissues after

JEM Vol. 210, No. 9
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Figure 3. After i.n. immunization, inte
grin 47 is induced in the mediastinal
LN- and lung-resident cells, followed by
the appearance of migratory cells in the
GI tissues. CD45.1+V2+CD4+OT-II cells were
transferred into naive CD45.2+ recipients. 2 h
after transfer, mice were immunized with OVA
protein + polyICLC via the i.n. route, and the
transferred CD45.1+V2+CD4+ cells in mediastinal LN (med LN), lung, SILP, colon, and MLN
were examined on days 1, 2, 3, 4, and 7 after
immunization. (A) Representative flow cytometry data showing CFSE dilution versus 47
expression in the med LN and lung at the
respective time points (top two rows) and
the frequency of adoptively transferred
V2+CD45.1+CD4+ T cells in the SILP, colon
and MLN (bottom three rows). (B) Cumulative
data showing frequency of 47+CFSElo cells
among total V2+CD4+ cells (left) and the
frequency of V2+CD45.1+ cells among total
CD4+ T cells (right). (C) Proliferation (CFSE
dilution) of the adoptively transferred
CD45.1+CD4+V2+ T cells is compared between the med LN (top) and MLN (bottom) of
the recipient mice on days 1, 2, 3, 4, and 7.

compartments in the FTY-treated group. Thus, based on the
in vivo labeling, time course, and FTY experiments, we were
able to conclude that after i.n. delivery of antigen, integrin
47 was induced on transferred T cells within the mediastinal
LNs and lungs and that inadvertent swallowing of i.n.-delivered
antigen was not a factor in our experimental system.
Next, we sought to compare the efficiency of lung DC–
primed and skin DC–primed T cells to migrate to the GI
tract. Mice were immunized i.n. or s.c. (2 h after adoptive
transfer of CFSE-labeled CD45.1+ OT-II cells to naive
CD45.2+ mice) with OVA protein and polyICLC. On day 7,
after immunization, the frequency of CD45.1+V2+ cells
in the small intestines and colon was 3–10 fold higher after
i.n. immunization than after s.c. immunization, demonstrating
that lung DC–primed congenic OT-II cells migrated to the
lamina propria with a significantly greater efficiency than skin
DC–primed OT-II cells (Fig. 5, a and b).
We next sought to examine the effect of blocking integrin
47 on lung DC–primed, 47-expressing cells to the GI
tract. After adoptive transfer of CFSE-labeled CD45.1+OT-II
cells and i.n. immunization with OVA/polyICLC, half of the

Figure 4. Administration of FTY-720
leads to accumulation of transferred
CD45.2+V2+CD4+ OT-II cells in the mediastinal LNs, but not in the MLNs, after
i.n. vaccination. CFSE-labeled CD45.1+
V2+CD4+OT-II cells were adoptively transferred to naive CD45.2+ recipients that were
immunized after 2 h with OVA protein and
polyICLC, delivered i.n. On days 0–3, the recipient mice were administered FTY-720
(1 µg/g mouse). The mice were sacrificed
on day 4, and the frequency of transferred
CD45.1+V2+CD4+ T cells was quantified in
the med LN, MLN, SILP, and colon. (A) Representative flow cytometry plot comparing the
frequency of adoptively transferred CD45.1+
CD4+ V2+ OT-II cells between WT mice (top)
and FTY-720 administered mice (bottom).
(B) Quantification of the number of transferred CD45.1+CD4+V2+ OT-II cells in the
med LN, MLN, SILP, and colon showing cumulative data from three independent experiments. *, P < 0.05; **, P < 0.01; ***, P < 0.001.
(C) Proliferation of the adoptively transferred
CD45.1+CD4+V2+ T cells is compared between WT and FTY-720 administered mice in
the indicated tissues.
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i.n. immunization were being generated in the lung-draining
LNs and not gut-draining LNs as a result of inadvertent swal
lowing of i.n.-delivered antigen. We used FTY-720, an in
hibitor of lymphocyte egress from LNs (Fig. 4) whereby
CFSE-labeled CD45.1+ OT-II cells were adoptively trans
ferred to naive CD45.2 recipients that were immunized after
2 h with OVA protein and polyICLC-delivered i.n. On days
0–3, recipient mice were administered FTY-720 (1 µg/g
mouse).The mice were sacrificed on day 4, and the frequency
of transferred CD45.1+V2+CD4+ T cells was quantified in
the mediastinal LNs, MLNs, SILP, and colon. An increase in
the frequency of transferred cells was noted in the mediastinal
LNs. In contrast, we noted a decrease in the frequency of
transferred cells in the MLNs, suggesting that antigen expo
sure and expansion of the transferred OT-II cells was occur
ring in the mediastinal LNs and not MLNs. As expected, a
significant decrease in the frequency of transferred cells was
noted in SILP and colon due to their arrest within the medi
astinal LN (Fig. 4, a and b). Furthermore, as shown in Fig. 4 c,
in the absence of gut exposure, the frequency of CFSElo
antigen-specific T cells was dramatically lowered in the gut

Ar ticle

Lung DC–mediated induction of integrin 47
is RA- and TGF-–mediated
RA has an unequivocal role in inducing 47 (Iwata et al.,
2004) and CD103+ DCs from PPs, and MLNs are capable of
metabolizing vitamin A into RA (Johansson-Lindbom et al.,
2005). To investigate the mechanisms mediating integrin 47
induction by lung DCs, we started by determining the pres
ence of retinal to RA-oxidizing enzymes, aldehyde dehydrog
enases (ALDHs) in lung DCs, using a fluorescent ALDH
substrate called ALDEFLOUR(Yokota et al., 2009). Both
CD103+CD11b and CD103CD11b+ lung DC subsets
Downloaded from http://rupress.org/jem/article-pdf/210/9/1871/639771/jem_20122762.pdf by Rockefeller University user on 21 August 2020

mice received 100 µg of anti-47 antibody delivered i.p. on
days 0 and 3, with the other half receiving PBS as a control.
As shown in Fig. 5 (c and d), anti-47 antibody administra
tion led to a significant reduction in the migration of CD4+
T cells to the small intestinal and colonic lamina propria,
as well as the intraepithelial compartments. Conversely, an
increase in the percentage of CD45.1+V2+CD4+ T cells
was noted in systemic sites such as the blood, spleen, and
lung where 47 is not required for cellular migration. This
demonstrated that i.n. immunization-induced OT-II cell
migration to the GI tract was mediated by 47.

Figure 5. i.n. immunization–induced migration of T cells to the GI tract is integrin 47-dependent and is more efficient than s.c. immunization–
induced T cell migration to the GI tract. (A and B) 2 h after adoptive transfer of CFSE-labeled CD45.1+V2+CD4+ OT-II cells to naive CD45.2+ mice,
the recipient mice were immunized i.n. or s.c. with OVA protein and polyICLC. On day 7 after immunization, the frequency of CD45.1+V2+CD4+ T cells
was determined in the SILP, colon, and MLN. Representative flow cytometry plots (A) and cumulative data from three independent experiments
(B) are shown. (C and D) After 2 h of adoptive transfer of CFSE-labeled CD45.1+V2+CD4+ OT-II cells to naive CD45.2+ mice, the recipient mice were immunized i.n. with OVA protein and polyICLC. On days 0 and 3, mice received 100 µg of anti-47 antibody delivered i.p. with the control mice receiving 100 µl
of PBS i.p. On day 7 after immunization, the frequency of CD45.1+V2+CD4+ T cells was determined in the colon, IEL, SILP, MLN, blood, spleen, med LN,
and lung. Representative flow cytometry plots (C) and cumulative data from three independent experiments comparing anti-47 and PBS administered
mice (D) are shown.
JEM Vol. 210, No. 9
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demonstrated the presence of ALDH at levels comparable to
MLN CD103+CD11b DCs (Fig. 6 a). This is in concurrence
with data generated by the Immgen Consortium (Heng and
Painter, 2008) and a similar study by Guilliams et al. (2010),
although the ability of lung DCs to induce integrin 47 was
not examined in either of those studies. Next, we investigated
the impact of inhibiting retinoic acid receptor (RAR) signaling

on 47 induction. Adding 1 µM RAR- inhibitor LE540 to
DC/OT-II cultures resulted in a significant reduction of 47
expression (Figs. 6, b and c). To test for RAR and TGF-
signaling in vivo, we used a dominant-negative RAR (dnRAR)
mouse crossed to OT-II on a RAG background (Rajaii et al.,
2008; Pino-Lagos et al., 2011), as well as a TGF-Rdef OT-II
mouse, respectively (see Materials and methods). WT OT-II
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Figure 6. Induction of integrin 47 by lung DCs requires RA and TGF- signaling. (A) Demonstration of ALDH activity in lung-derived DCs using
flow cytometry. The MFI of a fluorescent ALDH substrate was quantified for lung DCs in the presence (top two curves) or absence (middle two curves) of the
ALDH inhibitor-DEAB. MLN CD103+ DCs and splenic CD8+ DCs served as the positive and negative controls, respectively (bottom two curves). (B and C)
CD11c+ DCs isolated from the lung and MLN were pulsed with OVA and cultured with CFSE-labeled OT-II T cells at a ratio of 1:2 for 5–7 d. RAR- inhibitor,
LE540 (1 µM), or DMSO control is added to the DC/OT-II cultures. (B) Representative flow cytometry plots comparing the expression of 47 on CD4+OT-II
cells with and without RAR- antagonist LE-540. (C) Quantification of the number of 47+V2+CD4+ T cells induced by the respective DCs, in the absence
(black bars) or presence (white bars) of RAR- antagonist LE-540. (D) WT CD45.1+V2+CD4+OT-II cells, dnRAR-OT-II cells, and TGF-Rdef OT-II cells (described
in the Materials and methods) were transferred into CD45.2+ recipient mice and OVA/polyICLC was administered i.n. Cumulative data from three experiments
comparing the percentage of 47+CFSEloV2+CD4+ T cells between the WT OT-II, dnRAR OT-II, and TGF-Rdef OT-II recipients is shown. (E) After the transfer
of CD45.1+V2+CD4+OT-II cells, mice were immunized with OVA alone, with OVA + lipopolysaccharide (LPS), with OVA + polyICLC, or with polyICLC alone.
Cumulative data from three experiments comparing the percentage of 47+CFSEloV2+CD4+ T cells between these mouse groups.
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cells, dnRAR-OT-II cells, and TGF-Rdef OT-II cells were
transferred into congenic mice, and OVA/polyICLC was ad
ministered i.n. We found that 47 induction was attenuated
on TGF-RdefOT-II cells and virtually absent on dnRAROT-II cells, suggesting important roles for TGF- and RAR
signaling in lung DC-mediated 47 induction (Fig. 6 d).
Because low levels of integrin 47 can be induced
by cellular activation, we examined the role of adjuvant in
47 induction. After CD45.1+OT-II cell transfer into naive
CD45.2+ hosts, the recipient mice were immunized i.n. with
OVA alone, OVA/LPS, OVA/polyICLC, and polyICLC
alone. PolyICLC alone did not induce 47, whereas OVA
alone did, demonstrating the need for antigen presentation.
Additionally, OVA/LPS also induced 47, suggesting that
47 induction was not adjuvant specific (Fig. 6 e).
Finally, to test for involvement of polyICLC-induced
RIG-I– and TLR3-mediated DC maturation on 47 in
duction, we transferred CD45.1+OT-II cells into WT and
MDA-5/TLR3/ hosts (McCartney et al., 2009). No signi
ficant difference was noted between the MDA-5/TLR3/
and WT mice (unpublished data). Thus, we show that expres
sion of 47 on T cells after i.n. immunization is not induced
in a nonspecific fashion by polyICLC alone.
After i.n. immunization, induction
of integrin 47 is mediated by DCs
To test for the role of DCs in the induction of 47 after i.n.
immunization, we used two different experimental systems. First,
we used CD11c-DTR mice (Jung et al., 2002). CD11c-DTR
JEM Vol. 210, No. 9

chimeras (CD11c-DTR bone marrow into WT mice) were
generated (see Materials and methods) to avoid the lethality
of DT treatment in CD11c-DTR mice (Zammit et al., 2005).
24 h after diphtheria toxin (DT) administration, we trans
ferred CD45.1+ OT-II cells and immunized with OVA/poly
ICLC. CD11c-DTR mice administered PBS served as controls.
Significantly lower levels of 47 were induced on the trans
ferred V2+CD45.1+CD4+CFSElo cells after DT-mediated
ablation of DCs (Fig. 7, a and b). Because CD11c is also ex
pressed on various cells, including activated monocytes, macro
phages, and plasmacytoid DCs (pDCs), the CD11c-DTR
model cannot definitively distinguish the role of classical DCs
(cDCs) from activated monocytes and macrophages (Probst
et al., 2005; Zammit et al., 2005; Bennett and Clausen, 2007)
in 47 induction.To discern the role of lung cDCs in 47
induction, we used the recently described zDC-DTR mice
(Meredith et al., 2012a,b). In these mice, a zinc finger tran
scription factor, Zbtb46, which is specific to cDCs, is con
ditionally ablated, thus distinguishing the role of cDCs from
other cells types expressing CD11c.Again, zDC-DTR chimeras
(zDC-DTR bone marrow into WT mice) were generated
(see Materials and methods) to avoid the lethality of DT
treatment in zDC-DTR mice (Meredith et al., 2012a).
CD45.1+OT-II cells were transferred into zDC-DTR chimeras
24 h after DT ablation, and the mice were immunized with
OVA/polyICLC delivered i.n. zDC-DTR mice adminis
tered PBS served as controls. Lung DC depletion after DT
administration was confirmed (unpublished data). Signifi
cantly lower levels of 47 were induced on the transferred
1879
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Figure 7. After i.n. immunization, induction of
integrin 47 is mediated by DCs. DT was administered to CD11c-DTR chimeras (CD11c-DTR
bone marrow into WT mice), or zDC-DTR chimeras
(zDC-DTR bone marrow into WT mice) (described in
the Materials and methods). 24 h later, we transferred CFSE-labeled CD45.1+V2+CD4+ OT-II cells to
CD11c-DTR chimeras (A and B) or to zDC-DTR chimeras (C and D). Mice administered PBS served as
the respective controls. Representative flow cytometry plots (A and C) and cumulative data from three
experiments each (B and D), showing the in vivo
induction of integrin 47 on CFSEloCD45.1+
V2+CD4+ OT-II cells in CD11c-DTR and zDC-DTR
mice, respectively.

V2+CD45.1+CD4+CFSElo cells after DT-mediated ablation
of cDCs (Fig. 7, c and d). Thus, using two different methods
of DC depletion, we confirmed that lung DCs mediated the
induction of integrin 47 in vivo.
Ablation of lung CD11b+ cells attenuates
the induction of 47, whereas depletion
of langerin+ and Batf-dependent DCs does not
Contrary to the MLN, where only CD103+ DCs (and not
CD11b+ DCs) up-regulate gut-homing phenotype (JohanssonLindbom et al., 2005), we have found that both CD103+
and CD11b+ lung DC subsets express ALDH (Fig. 6) and
that both lung DC subsets up-regulated 47 and CCR9
in vitro (Fig. 1). Here, we wanted to test the effect of ablating
specific lung DC populations on the induction of 47
in vivo. To deplete CD11b+ lung DCs, we used CD11b-DTR
mice (Duffield et al., 2005). CD11b-DTR chimeras were cre
ated (CD11b-DTR bone marrow into WT mice). Two doses
of DT (25 ng/g) were administered on days 0 and 1. On
day 3, CD45.1+ OT-II cells were adoptively transferred,
and the mice were immunized with OVA and polyICLC.
4 d later, we examined the transferred cells for 47 induc
tion. CD11b-DTR chimera that received PBS instead of DT
served as controls. As shown in Fig. 8 (a and b), the 47 level
1880

on transferred V2+CD45.1+CD4+CFSElo cells in the blood,
lung and mediastinal LN were significantly lower in the DT
injected mice compared with mice that received PBS. Addi
tionally, we examined the transferred CD45.1+ T cells in the
spleen and MLN of recipient mice and observed similar at
tenuation of 47 induction (unpublished data). We tested
multiple doses of DT and found that two doses of 25 ng/g
mouse, 1 d apart, were optimal in effecting depletion of
CD11b+ lung DCs and mediastinal LN DCs (Fig. 8, c and d).
One dose of DT resulted in monocyte depletion in the blood,
but not in lung tissue, and three doses of DT were lethal after
i.n. administration of PolyICLC (unpublished data).
To examine the effect of depleting CD103+ lung DCs,
we used two systems: temporal (Langerin DTR; Kissenpfennig
et al., 2005) and constitutive (Batf3/; Hildner et al., 2008).
In the Langerin DTR mice, 1 d after administration of DT,
CD45.1+OT-II cells were adoptively transferred and the mice
were immunized with OVA and polyICLC. 4 d later, we
examined the transferred cells for 47 induction. Langerin
DTR mice administered PBS served as controls.There was no
difference in the levels of 47 between PBS- and DT-treated
mice (Fig. 9, a and b). Next, we compared Batf3/ and WT
mice. Again, after adoptive transfer of congenic OT-II cells
and immunization with OVA/PolyICLC, no difference was
observed between the levels of 47 induced on the adoptively
Lung dendritic cells' intestinal homing | Ruane et al.
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Figure 8. Ablation of CD11b+ cells attenuates the induction of 47 on transferred
OT-II cells after i.n. immunization. Two doses
of DT were administered to CD11b-DTR chimeras
(CD11b-DTR bone marrow into WT mice; described
in the Materials and methods) on days 0 and 1.
On day 3 after DT, CFSE-labeled CD45.1+V2+
CD4+ OT-II cells were transferred and the mice
were immunized i.n. with OVA/polyICLC. PBSadministered CD11b-DTR mice served as controls.
Representative flow cytometry plots (A) and
cumulative data from three independent experiments showing the induction of integrin 47
on adoptively transferred CD45.1+V2+CD4+ OT-II
cells in PBS or DT-administered animals (B).
(C) Representative flow cytometry plots comparing the frequency of MHCII+CD11c+-gated
CD11c+CD11b+ cells in the lung (top) and med LN
(bottom) of CD11b-DTR bone marrow chimeric
mice administered PBS or DT. (D) Quantification
of CD11b and CD11b+ DC in the lung and med
LN of CD11b-DTR bone marrow chimeric administered PBS or DT, showing cumulative data from
three independent experiments.
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transferred cells (Fig. 9, c and d). Together, these data suggest
that in vivo, lung CD11b+ DC subsets are more proficient in
inducing 47 than the CD103+ DCs.
Lung DCs induce protective immunity in the GI tract
Having observed that lung DCs can license T cells to migrate
to the GI tract, we wanted to examine whether protective gut
immunity can be induced after targeting of lung DCs by i.n.
immunization. We first transferred CD45.1+ OT-II cells into
naive mice and immunized i.n. or s.c., with unimmunized
mice serving as controls. After gavage of pathogenic Salmonella
typhimurium expressing OVA, all the unimmunized or s.c.immunized mice died between days 6–9. In contrast, survival
in the i.n. immunized mice was prolonged by 2–3 d (unpub
lished data). Transferred V2+CD45.1+CD4+ T cells were
enriched in the small and large intestinal lamina propria and
intraepithelial compartments in the i.n.-immunized mice
compared with the s.c.-immunized animals (unpublished data).
Having observed that i.n. immunization extended the sur
vival of Salmonella-challenged animals in the transgenic OVA
TCR model, we asked whether a protective immune response
could be generated from the endogenous immune repertoire.
WT mice were immunized with OVA/polyICLC (100 µg
and 50 µg, respectively) delivered i.n. or s.c. in a prime-boost
fashion or p.o. with OVA/Cholera Toxin (50 mg/ 2 µg;
a booster dose of the vaccine was given 4 wk after priming),
JEM Vol. 210, No. 9

and challenged orally with Salmonella-OVA. Survival was
significantly greater in the i.n.-immunized mice compared
with unimmunized mice, with 36% of the mice demonstrat
ing long term survival (>40 d, P < 0.05; Fig. 10 a).Pathologi
cal examination of the liver, spleen, and MLN demonstrated
significant disruption of hepatic, splenic, and LN architecture,
vasculitis, coagulative necrosis, and intravascular thrombi in
the challenged, unimmunized mice compared with WT mice,
similar to previous studies (Jones and Falkow, 1996; Griffin and
McSorley, 2011). In contrast, the liver, spleen, and MLN of i.
n.-immunized mice were indistinguishable from WT mice
(Fig. 10 b). This is also reflected in the inflammation score
(Wu et al., 2005) for each of the vaccinated groups (Fig. 10 c).
Stool cultures showed a significantly higher level of Salmonella
in the stool of i.n. immunized mice on days 2 and 4 after
challenge (unpublished data), perhaps because of luminal se
questration of the bacteria. Interestingly, the i.n.-immunized
mice showing long term survival continued to demonstrate
detectable levels of Salmonella in the stool even at day 40 (un
published data). Finally, we also immunized naive C57BL/6
mice with heat and paraformaldehyde inactivated Salmonella
typhimurium, delivered i.n. or s.c. Significantly lower levels of
Salmonella CFUs were observed in the spleen of i.n.-immunized
mice compared with unimmunized mice (Fig. 10 d). Thus,
using three different models of protection against pathogenic
Salmonella, we found that i.n. immunization extends survival,
1881
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Figure 9. Ablation of CD103+ DCs does not
impact the induction of 47 on transferred
OT-II cells after i.n. immunization. (A and B)
DT or PBS was administration to langerin-DTR
mice (described in the Materials and methods).
24 h later CFSE-labeled CD45.1+V2+CD4+ OT-II
cells were transferred and the mice were immunized
with OVA/polyICLC. Representative flow cytometry plots (A) and cumulative data from three
experiments (B) are shown, comparing the expression of 47 on CFSElo CD45.1+V2+CD4+
OT-II cells. (C and D) CD45.1+V2+CD4+ OT-II cells
were transferred to WT or batf3/ mice, followed by immunized with OVA/polyICLC, delivered
i.n. Representative flow cytometry plots (C) and
cumulative data from three experiments (D) are
shown, comparing the expression of 47 on
CFSElo CD45.1+V2+CD4+ OT-II cells.
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Figure 10. i.n. immunization protects against enteric challenge with highly pathogenic Salmonella. (A–C) C56Bl/6 mice were immunized with
OVA/polyICLC delivered i.n. or s.c. in a prime-boost fashion or p.o. with OVA/CT, and challenged orally 7 d after the boost with Salmonella-OVA. Unimmunized mice challenged with Salmonella-OVA served as controls. Data from three independent experiments is presented here. (A) Kaplan-Meier curves
comparing the survival of unimmunized (red) mice or mice immunized i.n. (green), s.c. (black), or p.o. (blue) against oral challenge with Salmonella-OVA
(106PFU). (B) Hematoxylin and eosin sections examining the MLN (i, v, ix, and xiii), spleen (ii, vi, x, and xiv), and liver (iii, vii, xi, and xv), all at 200× magnification (bar, 100 µm), and liver (iv, viii, xii, and xvi) at 400× magnification (bar, 50 µm) from a WT (unimmunized, unchallenged) mouse (i–iv), an unim
munized, Salmonella-challenged mouse (v–viii), a representative i.n.-immunized, Salmonella-challenged mouse #1 (ix–xii), and a representative
i.n.-immunized, Salmonella-challenged mouse #2 (xiii–xvi). (C) Cumulative data from three experiments showing the inflammation score from the WT
(unimmunized, unchallenged), unimmunized, and Salmonella-challenged groups. (D) C56Bl/6 mice were immunized with heat and paraformaldehydeinactivated S. typhimurium delivered i.n. or s.c. in a prime-boost fashion, and challenged orally 7 d after the boost with Salmonella-OVA. Unimmunized
mice challenged with Salmonella-OVA served as controls. CFU of S. typhimurium per gram of splenic tissue is compared between the WT, s.c.-immunized,
and i.n.-immunized mice.
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and is associated with a striking absence of pathology in the
liver and spleen in the immunized compared with unimmu
nized mice.
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DISCUSSION
In this study, we propose a novel pathway of lung DC–mediated
T cell migration to the GI lamina propria via induction of
gut-homing integrin 47. Several lines of evidence pointed
us in this direction. First, lungs harbor extrahepatic stores of
vitamin A (Okabe et al., 1984; Dirami et al., 2004). Second,
lungs are anatomically juxtaposed to the liver (the largest store
of vitamin A in the body), directly receiving hepatic blood.
Third, lung DCs express the enzyme RALDH (Guilliams et al.,
2010) and are capable of oxidizing Vitamin A into RA. Thus,
lung DCs have access to the necessary substrate (Vitamin A)
and are equipped with the enzymatic machinery required to
metabolize it and generate RA.These facts led us to hypothe
size that lung DCs may up-regulate integrin 47 and in
duce a gut-homing phenotype on T cells.
We have used multiple experimental approaches to
test our hypothesis. First, lung DCs co-cultured with OVAspecific OT-II cells in the presence of OVA express integrin
47 at levels comparable to those induced by MLN CD103+
DCs. Second, integrin 47 is induced on adoptively trans
ferred OT-II cells after i.n. immunization. Third, T cells can
be tracked to the GI lamina propria after i.n. immunization
and fourth, T cell migration can be blocked by anti-47
antibody, causing the transferred T cells to accumulate in
systemic compartments.
It may be argued that i.n. immunization may lead to inad
vertent swallowing of antigen and targeting of GI-resident
DCs that are known to induce gut migration of T and B cells.
To exclude this possibility, we first used a time course experi
ment to identify the populations targeted by i.n. delivery of
fluorescent, DC-specific antibodies. We could readily detect
targeting of mediastinal LN- and lung-resident DCs, but not
GI-resident DCs. Because this does not exclude migration of
antigen to the GI tract, we performed experiments to block
the egress of T cells from LNs using FTY-720. In doing so, we
observed an accumulation of transferred cells in the mediasti
nal LNs and, in contrast, a drop in transferred cell frequency
in MLNs in mice given FTY-720, thereby confirming that
i.n. immunization-mediated expansion of transferred cells
was occurring in the former and not the latter lymphoid sites.
Finally, we observed early (day 2) proliferation of transferred
cells within the mediastinal LNs and the appearance of inte
grin 47 on mediastinal LN- and lung-resident cells (day 3),
followed by the migration of transferred cells to GI compart
ments (day 4), which could be blocked with an anti-47
antibody. These data extend the work of Ciabattini et al.
(2011), who recently demonstrated that after i.n. immuniza
tion, antigen-specific T cells trafficked to distal skin-draining
LNs in a CD62L-dependent fashion and to the MLNs in an
47-dependent fashion. However, unlike in the present
study, mechanisms of induction of 47, i.e., the role of lung

DCs or the physiological relevance of these pathways was not
explored by Ciabattini et al. (2011).
It is interesting to note that whereas migration to GI sites
was blocked using an anti-47 antibody, migration to the
systemic sites was not. In fact, there was a nonsignificant
increase in the frequency of transferred cells in other sites
examined, including the lungs. This lends specificity to our
experimental approach, as migration of T cells to the lungs
has been shown to be independent of 47/MAdCAM but
dependent on l-Selectin/PNAd, 41/VCAM-1 and LFA-1
(Xu et al., 2003).
To examine the role of lung DCs in the in vivo induction
of integrin 47, we used two different conditional knock
out models. Use of the CD11c DTR leads to the depletion of
85–90% of CD11c+ DCs (Bennett and Clausen, 2007). How
ever, because this model cannot distinguish between classical
DCs, activated monocytes, and alveolar macrophages, all of
which express CD11c and are therefore depleted (Probst et al.,
2005; Zammit et al., 2005), we also used the newly described
zDC-DTR model (Meredith et al., 2012a,b). Significantly
attenuated numbers of transferred congenic cells expressing
47 were seen in both models, demonstrating that lung
DCs induced integrin 47 after i.n. vaccination. These
results need to be interpreted with the caveat that both
DT-induced depletion of DCs and nasal administration of
polyICLC are likely associated with lung inflammation (Tittel
et al., 2012).We speculate that local inflammation is responsible
for the variability observed in the levels of 47 expressed on
transferred cells isolated from various compartments, the ex
pression being high on cells isolated from the lungs compared
with the cells isolated from the mediastinal LN and blood, or
from the spleen and MLN (unpublished data), where a more
profound attenuation of 47 was seen.
Thus, based on the data generated by different experi
mental approaches, we propose that after i.n. immunization,
lung and mediastinal LN-resident DCs are targeted which in
turn induce the expression of integrin 47 on T cells, result
ing in their localization to the GI tract. Herein, we provide
novel functional evidence of mucosal cross talk mediated by
DCs.This provides a mechanistic insight to the observation of
T cell responses in the GI lamina propria after i.n. challenge
(Esplugues et al., 2011; Masopust et al., 2010) or after the appear
ance of antigen-specific T cells in the MLN after i.n. immu
nization (Ciabattini et al., 2011).
Although the mechanisms underlying 47 induction
appear to be conserved between lung- and GI-resident DCs,
the DC subsets involved show striking differences. For example,
consistent with studies of 47 induction by gut DCs (Iwata
et al., 2004; Kang et al., 2011), our results show that RA and
TGF- are required in the lung DC–mediated induction
of 47. Notably, in addition to an in vitro culture system,
we have used novel, dominant-negative RAR-OTII Rag/
mice and TGF- receptorfl/fl-CD4CRE OT-II Rag/ mice to
address these questions. Splenic OT-II cells from the dominantnegative RAR-OTII Rag/ mice and TGF- receptorfl/flCD4CRE OT-II Rag/ mice were used as donor cells, so local
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Initially, we used polyICLC alone (without antigen) but could
not observe any significant induction of 47, whereas OVA
alone induced 47 on transferred OTII cells. In addition,
using the MDA5/TLR3/ mice, we were able to confirm
that i.n. immunization-induced 47 was not a nonspecific
effect of adjuvant. Additionally, we have tested the use of differ
ent adjuvants in the induction of 47 after i.n. immunization
and observed no significant differences between them (unpub
lished data). Combined, we speculate that in the right cellular
context, i.e., in the presence of local availability of RA and
TGF-, the use of an adjuvant amplifies the induction of 47
because of DC and T cell activation, as well as DC migration.
Having shown that lung DCs induce 47 and induce
cellular migration to the GI tract, we wanted to study if
pathogen-specific intestinal immunity can be induced by tar
geting lung DCs. We chose Salmonella typhimurium, a patho
gen of global significance (Levine, 2006) that is transmitted
across the intestinal mucosa and causes a spectrum of diseases
ranging from localized intestinal infection to severe systemic
illness (Griffin and McSorley, 2011). Notably, although Salmonella is not a lung pathogen, we used this model as a tool to
examine i.n. vaccine induced protection against Salmonella
invasion across the GI tract. To confirm protection against
enteric challenge with Salmonella , we have used three different
experimental systems: (1) passive immunization using trans
ferred OT-II cells followed by i.n. immunization, where
we demonstrated a modest increase in survival; (2) active
prime-boost immunization with OVA showing a signifi
cantly increased survival and lack of systemic pathology in the
i.n.-immunized mice; and (3) active prime-boost immuniza
tion using inactivated Salmonella showing reduced systemic
burden in the i.n.-immunized mice. Thus, using multiple
experimental systems, we were able to show that lung DCs
targeted by i.n. immunization are able to induce protective
immunity within the GI tract. Notably, in mice that received
s.c. vaccine, a nonsignificant increase in survival was also ob
served. We hypothesize this to be due to the systemic immu
nity generated by s.c. vaccine and plan to study this further
with the use of IgA-deficient, CD103/ and B7/ mice.
To conclude, in this manuscript we challenge the dogma
that only CD103+ gut-resident DCs can recruit T cells to the
GI tract. Rather, we provide compelling evidence that lung
DCs targeted by i.n. immunization are capable of inducing
robust levels of gut-homing integrin 47 and licensing
T cells to migrate to the GI tract. Pathways of recruitment
of antigen-specific immune cells to the gut are therefore
much more promiscuous than previously appreciated. There
appears to be considerable, albeit hitherto unrecognized, DCorchestrated, mucosal cross talk that can inform the rational
design of novel vaccines.

MATERIALS AND METHODS
Mice. C57BL/6 (B6), C57BL/6-Tg(TcraTcrb)425Cbn/J (OT-II), and
C57BL/6-Tg(TcraTcrb)1100MjbJ (OT-I) mice were purchased from Taconic
Farms or bred at The Rockefeller University. 6–8-wk-old CD11c-DTR
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lung DC subsets in these mice are not relevant here. However,
these mice will be described in detail in future studies.
In contrast to the existing literature showing that CD103+
MLN DCs induce integrin 47, whereas the CD11b+ MLN
DCs do not, we have found that both CD103+ and CD11b+
lung DC populations induced integrin 47, the expression
being higher in the lung CD11b+ DC induced co-cultures
in vitro. Because these differences were novel and unexpected,
we examined them by using in vivo DC depletion models.
To deplete the CD103+ DC populations, we used Langerin DTR
(Bennett et al., 2005) mice and could not detect any significant
differences in the level of 47 induction between the lan
gerin depleted and replete mice. To further confirm the effect
of CD103+ DC depletion, we used the Batf3/ mice, in which
the deletion of the transcription factor Batf3 results in ablation
of cross presenting, CD103+ tissue DCs (Hildner et al., 2008).
Again, no significant differences in the induction of 47 were
observed between WT and Batf3/ animals. Finally, to deplete
the CD11b+ lung DCs, we used the CD11b DTR mice. Both
CD11b-expressing alveolar macrophages and DCs are depleted
in this model; however, the use of zDC-DTR demonstrates the
role of classical DCs. Attenuated levels of 47 were observed
in the mice in which CD11b-expressing cells were depleted. It
may be noted that although the dose of DT administered to the
Langerin DTR and CD11b DTR mice was different, we were
guided by previous studies on the dose required to deplete the
respective DC subsets (Duffield et al., 2005; Kissenpfennig
et al., 2005). Additionally, in this study, we confirmed the deple
tion of respective lung DC populations. Therefore, in contrast
with MLN DCs, both CD103+ and CD11b+ lung DC popula
tions induced integrin 47 in vitro, although in vivo, the
CD11b+ populations appeared to have a more dominant effect
on the induction of 47. Furthermore, within the hetero
geneous CD11b+ population, we observed a striking dif
ference between the CD24+ and CD64+ subsets, where the
CD24+CD11b+ DCs induced robust levels of 47 and
CCR9, whereas CD64+CD11b+ cells did not. We speculate
that whereas the migratory gut CD103+ DCs use dietary
and biliary sources of vitamin A to generate RA ( JaenssonGyllenbäck et al., 2011), the lung DCs either use hematoge
nous vitamin A, released from hepatic stores, or local stores of
vitamin A (Dirami et al., 2004; Okabe et al., 1984). Thus, the
predominance of CD103+ DC in mediating gut-homing, as
in the case of MLN, is not observed in case of lung DCs.
This further allows us to speculate that specific DC populations,
i.e., CD103+ DCs, may not be preconditioned to metabolize
vitamin A but rather, they may acquire this property based on
local environmental factors like the availability of vitamin A,
TLR ligands, or other inflammatory stimuli. Detailed mechanis
tic studies are underway to further address this question, includ
ing a study of the relative expression of RALDH and the effect
of adjuvants on RALDH expression by lung DC subsets.
Integrins may be induced via nonspecific stimuli, such as
cellular activation (Laudanna et al., 2002). Because our in vivo
experimental system involved use of the TLR-3 agonist, poly
ICLC, we tested its effect on the induction of integrin 47.
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Antibodies. The following reagents were purchased from BD: anti-CD3
(500A2), anti-CD3 (145–2011), anti-CD103 (M290), anti-CD4 (RM4-5),
and anti-CD8 (53–6.9). The following reagents were purchased from eBio
science: anti-MHCII (M5/114.15.2), anti-IFN- (XMG1.2), anti-CD4
(RM4-5), and anti-CD8 (53–6.9). The following antibodies were obtained from
BioLegend: anti-CD45 (30-F11), anti-CD45.1 (A20), anti-CD45.2 anti-CD11c
(N418), anti-CD11b (M1/70), anti-IFN- (XMG1.2), anti-CD103 (M290),
anti-LPAM-1 (DATK32), anti-CD24 (M1/6a), anti-CCR9 (CW12), anti-CD64
(X54-51711), and anti-TCRV2 (B20.1). AQUA (L34957) was obtained from
Invitrogen, and CFSE was purchased from Sigma. Anti-CD205 (NLDCC) was
produced locally, as previously described (Trumpfheller et al., 2006).
Adoptive cell transfer. OT-I or OT-II mice were used as cell donors for
adoptive transfer into syngeneic recipient animals. Lymphocytes were iso
lated from the spleen and labeled with 5 µM CFSE (Invitrogen) for 10 min
at 37°C. After washing twice with PBS containing 3% FCS, 7 × 106 cells per
mouse were injected via the retroorbital venous plexus.
Immunization. CFSE-labeled OT-I or OT-II mice were adoptively trans
ferred into syngeneic age- and gender-matched WT mice and controls. 2 h
later, the recipient mice were immunized i.n., i.t., or s.c. with 100 µg OVA
(LPS-free; Seikagaku Corp.) and 50 µg of poly ICLC (Oncovir, Inc.) using
Isoflurane as a short-acting inhalant anesthetic. Additionally, recipient mice
were immunized p.o. with 50 mg of OVA (Grade III; Sigma-Aldrich) and
2 µg of cholera toxin (Sigma-Aldrich). All animals were given food and
water ad libitum.
Tissue harvesting and cell preparation. Mice were euthanized and
blood was obtained from the experimental mice by cardiac puncture. Lung
mononuclear cell isolation was performed as previously described (Vermaelen
et al., 2001). In brief, after sacrificing the animals, the pulmonary circulation
was perfused with saline to remove the intravascular pool of cells. Lungs were
carefully separated from thymic and cardiovascular remnants and removed in
JEM Vol. 210, No. 9

toto. Organs were thoroughly minced using iridectomy scissors and incu
bated for 60 min in digestion medium containing collagenase D in a humidi
fied incubator at 37°C and 5% CO2. In the last 5 min, 10 mM EDTA was
added.Tissue fragments were disrupted mechanically by pipetting and passed
through a 70-µm cell strainer. Mononuclear cells were washed twice in
RPMI before use in subsequent experiments as described below.
The spleen and LN were harvested in RPMI media with 5% FCS,
mashed between two sterile glass slides, washed with RPMI complete media,
and then filtered through a 70-µm filter. Spleen but not LN samples went
through subsequent ACK lysis, were washed twice, and counted. LN singlecell suspensions were prepared by incubation with 400 U/ml collagenase D
at 37°C for 30 min.
Intestinal lymphocytes were isolated and prepared as previously de
scribed (Mucida et al., 2007). In brief, small and large intestines were re
moved and placed in cold HBSS media containing 5% FCS. The intestines
were carefully cleaned from the mesentery and flushed of fecal content.
Intestines were opened longitudinally and then cut into 1-cm pieces. The
intestinal tissue was incubated with 1.3 mM EDTA (Cellgro) in HBSS at
37°C for 1 h.The supernatants containing intestinal epithelial cell (IEC) with
some superficial villi cells, referred to as the “IEC fraction,” were collected
and layered over a discontinuous 40/80% Percoll gradient, and centrifuged at
2,800 rpm for 30 min. Cells from the 40/80% interface were collected,
washed, and resuspended in complete RPMI media. These purified cells
constituted the intraepithelial lymphocyte (IEL) population. To isolate the
lamina propria lymphocytes (LPL), the remaining intestinal tissue was minced
and transferred to conical tubes. The minced pieces were resuspended in
20 ml of complete RPMI containing 0.125 mg/ml of collagenase (SigmaAldrich) and shaken at 200 rpm for 50 min at 37°C. The tissue suspension
was collected and passed through a 70-µm cell strainer and the cells were
pelleted by centrifugation at 1,200 rpm.The cells were then resuspended and
layered onto a 40/80% Percoll gradient, centrifuged, and processed as de
scribed above for the IEL preparation.
DC isolation. Single-cell suspensions were isolated from the murine lung,
spleen, mesenteric, mediastinal, and skin-draining LNs as described above.
CD11c+ cells were isolated as previously described (Ing et al., 2006) using
CD11c magnetic beads (Miltenyi Biotec). In brief, the cells were washed in
1 ml of MACS buffer (Miltenyi Biotec), before 30-min incubation on ice with
CD11c+ beads. The cellular suspensions were washed twice in MACS buffer
and passed through a magnetic column. CD11c+ cells were isolated by positive
selection, washed, resuspended in complete RPMI medium, and counted be
fore co-culture with T cells, as described in the following section.
Lung DC subset isolation. Lung mononuclear cells were isolated as
described above. Using magnetic beads, CD11c+ cells were enriched and
sorted on FACSAria (BD) as B220MHC II+CD11chiCD103+CD11b and
B220MHC II+CD11chiCD103CD11b+ subsets.
In vitro DC/T cell co-cultures. The culture medium used for DC/T cell
cultures was RPMI (Invitrogen) supplemented with 10% heat-inactivated
FCS, 2 mM l-glutamine, 100 U/ml penicillin, 100 µg/ml streptomycin, and
5 mM -mercaptoethanol (all from Sigma-Aldrich). Allogeneic T cells were
isolated from spleens of C57BL/6 mice by excluding B220+, F4/80+,
CD49b+, and I-Ab+ cells with anti–rat IgG Dynabeads (Invitrogen). T cells
were added to round-bottom microtest wells at 105/well and mixed with
isolated DCs at a DC/T cell ratio of 1:2, 1:5, and 1:10 in the presence of
OVA (25 µg/ml final). After 5 d, the expression of 47 on proliferating
T cells was evaluated by FACS. For the retinoic acid inhibition assays, the
DC/T cell co-cultures were incubated with 1 µM of RAR- antagonist,
LE540 (Wako; dissolved in DMSO at a stock concentration of 1 mM), and
added to cultures at final concentration of 1 µM.
Flow cytometric analyses, intracellular staining and gating schema.
Cells were isolated as described in the preceeding section. Before staining,
cells were washed and resuspended in staining buffer containing 1× PBS,
2% BSA, 10 mM EDTA, and 0.01% NaN3. To block nonspecific staining,
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(B6.FVB-Tg(Itgax-DTR/EGFP)57Lan/J) mice were purchased from The
Jackson Laboratory. CD4CRETGF-Rfl/fl OT-II mice and the dnRAR-OT-II
mice were provided by the Mucida Laboratory (The Rockefeller University,
New York, NY). In brief, CD4CRE mice were crossed with TGF-Rfl/fl
mice (provided to the Mucida laboratory by the National Cancer Institute,
Rockville MD) to specifically deplete TGF-R from CD4 T cells. To avoid
autoimmune disease and premature death in CD4CRE x TGF-Rfl/fl mice,
these animals were backcrossed to OT-II Rag/ animals to obtain TGF-Rdef
OT-II (TGF-Rdef) mice (these mice will be described elsewhere). To analyze
RA signaling in CD4+ T cells, CD4CRE mice were crossed with dnRARfl/fl
mice(Pino-Lagos et al., 2011; Rajaii et al., 2008) to specifically express the
dominant-negative form of RAR in CD4+ T cells. To address the importance
of RA for mucosal T cell migration after specific T cell activation, these ani
mals were backcrossed to an OT-II Rag/ background. MDA-5/TLR3/
mice (McCartney et al., 2009) were provided by M. Colonna (Washington
University, St. Louis, MO).
Bone marrow chimeras were created by transferring bone marrow from
CD11c-DTR, zDC-DTR, and CD11b DTR mice into lethally irradiated
WT C57BL/6 mice to avoid lethality associated with DT treatments of
CD11c-DTR (Jung et al., 2002; Zammit et al., 2005), zDC-DTR (Meredith
et al., 2012a), or CD11b DTR. In brief, C57BL/6 hosts underwent two
treatments of 500 rads in an animal -irradiator 3-h apart, and 2.5 × 106
bone marrow cells from CD11c-DTR, zDC-DTR, and CD11b-DTR donor,
respectively, were transferred i.v. The resulting mice (referred to herein as
CD11c-DTR, zDC-DTR, and CD11b-DTR) were housed under immuno
compromised mouse conditions and treated regularly with 2 mg/ml neomycin
from Sigma-Aldrich in their drinking water. The chimeric mice were fully
reconstituted and ready for experimental use after 6 wk.
Mice were maintained in specific pathogen–free conditions. Pro
tocols were approved by the The Rockefeller University Animal Care and
Use Committee.

ALDEFLUOR assay. ALDH activity was determined using the ALDE
FLUOR staining kit (STEMCELL Technologies) according to the manu
facturer’s instructions, with some modifications. In brief, LN and lung
mononuclear cells were resuspended at 106 cells/ml in ALDEFLUOR assay
buffer containing activated ALDEFLUOR substrate (final concentration,
1.5 µM) with or without the aldehyde dehydrogenase inhibitor DEAB (final
concentration, 45 µM) and incubated for 30 min at 37°C. For immunophe
notyping of ALDEFLUOR-reactive cells, the cells were subsequently stained
with PE-, PE-Cy7–, A700-, PerCP Cy5.5-, and Pacific blue–conjugated
mAbs in ice-cold ALDEFLUOR assay buffer. ALDEFLUOR-reactive cells
were detected in the FITC channel using multi-parameter flow cytometry, as
described above.
In vivo DT treatment. DT purchased from Sigma-Aldrich was prepared
in a sterile solution of PBS at a concentration of 1 mg/ml. Transient DC de
pletion was effected in CD11c-DTR chimeras by a single i.p. injection of
200 ng DT; in zDC-DTR mice, a single 100-ng i.p. injection of DT was
given i.p.; in CD11b-DTR mice, two 500-ng injections were given on days 0
and 1 i.p.; and in langerin DTR mice, a single dose of 100 ng of DT was
given i.p.
Salmonella challenge. Recipients of adoptively transferred OT-II cells, mice
immunized i.n. or s.c. with OVA, and mice immunized with heat inactivated,
paraformaldehyde-fixed Salmonella (106 CFU) were inoculated orally by ga
vage with WT Salmonella-OVA (106 CFU/animal). Mice were monitored with
recording of daily weights. Stool culture was performed by culturing pre
weighed stool pellets on days 2, 4, 8, 12, and 40 after challenge (day 40 stool
cultures were performed in the long-term survivors to detect for persistence
of Salmonella in the stool) and expressed as Salmonella CFU/g of stool tissue.
For splenic cultures, the spleen was harvested from the Salmonella-challenged
mice on day 6 after challenge, and then weighed, ground in LB broth, and in
oculated on Macconkey’s Agar in serial dilutions. Kaplan-Meier curves were
used to determine the frequency of survival among the challenged mice.
Statistical analysis. Statistical significance was evaluated using a two-tailed
Student’s t test with a 95% confidence interval. Results are expressed as
means ± SD. Analysis was performed with a Prism 4 program (GraphPad
Software, Inc.).
Online supplemental material. Fig. S1 shows the gating strategy used
to identify and sort lung DCs. Online supplemental material is available at
http://www.jem.org/cgi/content/full/jem.20122762/DC1.
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